Division of Sexual Medicine, Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Johns Hopkins Hospital, Marburg 407, 600 North Wolfe Street, Baltimore, MD 21287, USA.
Urol Clin North Am. 2011 May;38(2):185-94. doi: 10.1016/j.ucl.2011.02.005.
Advances have recently been made in both medical and surgical management of priapism, and these offer improvements in the level of care afforded such patients. Further developments can be expected based on ongoing progress, particularly in the area of molecular science, which is the primary source for driving novel therapeutic approaches. Continued action to address the health care administrative concerns of those most commonly affected by priapism, specifically individuals with sickle cell disease, is also appropriate. All successes in these arenas ensure that afflicted individuals avoid the health burdens of priapism and preserve sexual function.
近年来,在阴茎异常勃起的医学和手术治疗方面都取得了进展,这为患者提供了更好的治疗水平。基于正在进行的进展,特别是分子科学领域的进展,预计还会有更多的进展,因为分子科学是推动新治疗方法的主要来源。继续采取行动,解决那些受阴茎异常勃起影响最严重的人群的医疗保健管理问题,特别是镰状细胞病患者,也是合适的。在这些领域取得的所有成功都确保了受影响的个体避免了阴茎异常勃起的健康负担,并保持了性功能。